Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Protalix Biotherapeutics (NY: PLX ) 1.090 UNCHANGED Official Closing Price Updated: 8:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Protalix Biotherapeutics < Previous 1 2 3 Next > Mid-Day Market Update: Crude Oil Rises 1%; iRhythm Technologies Shares Plunge June 02, 2021 `Midway through trading Wednesday, the Dow traded up 0.33% to 34,689.77 while the NASDAQ rose 0.16% to 13,758.43. The S&P also rose, gaining 0.30% to 4,214.55. The U.S. has... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Protalix Shares Hits 52-Week Low After Adverse Event Reported In Fabry Disease Trial With PRX-102 June 02, 2021 Protalix BioTherapeutics Inc (NYSE: PLX) and Chiesi Farmaceutici S.p.A. have provided an update on the clinical development of pegunigalsidase alfa (PRX... Via Benzinga 40 Stocks Moving In Wednesday's Mid-Day Session June 02, 2021 Gainers BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously... Via Benzinga Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety Stocks That Hit 52-Week Lows On Wednesday June 02, 2021 Before 10 a.m. ET on Wednesday, 8 companies hit new 52-week lows. Highlights: Dun & Bradstreet Hldgs (NYSE:DNB) was the biggest company by market cap to set a new 52-... Via Benzinga Looking Into Protalix BioTherapeutics's Return On Capital Employed May 20, 2021 Protalix BioTherapeutics (AMEX:PLX) reported Q1 sales of $11.32 million. Earnings fell to a loss of $3.71 million, resulting in a 230.5% decrease from last quarter. In Q4,... Via Benzinga Stocks That Hit 52-Week Lows On Friday May 14, 2021 Before 10 a.m. ET on Friday, 24 stocks hit new 52-week lows. Noteworthy Mentions: The largest company in terms of market cap to set a new 52-week low was Canadian... Via Benzinga Earnings Scheduled For May 14, 2021 May 14, 2021 Companies Reporting Before The Bell • Sogou (NYSE:SOGO) is projected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is estimated to report... Via Benzinga The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts May 14, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... Via Benzinga Exposures Product Safety Earnings Preview for Protalix BioTherapeutics May 13, 2021 On Friday, May 14, Protalix BioTherapeutics (AMEX:PLX) will release its latest earnings report. Here is Benzinga's outlook for the company. Net Income, Earnings, And Earnings Per... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday May 11, 2021 Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... Via Benzinga 22 Stocks Moving in Monday's Pre-Market Session May 03, 2021 Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn... Via Benzinga Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates May 01, 2021 Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid... Via Benzinga Mid-Afternoon Market Update: Dow Drops 90 Points; Fed Leaves Rates Unchanged April 28, 2021 Toward the end of trading Wednesday, the Dow traded down 0.26% to 33,894.93 while the NASDAQ fell 0.01% to 14,090.09. However, the S&P gained 0.13% to 4,192.05. The U.S. has... Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities 60 Biggest Movers From Yesterday April 29, 2021 Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of... Via Benzinga Why Protalix BioTherapeutics Stock Is Plunging Today April 28, 2021 Investors did not like the company's latest regulatory update. Via The Motley Fool Mid-Day Market Update: Crude Oil Rises 2%; Protalix BioTherapeutics Shares Plunge April 28, 2021 Midway through trading Wednesday, the Dow traded down 0.33% to 33,874.02 while the NASDAQ fell 0.07% to 14,079.66. The S&P also rose, gaining 0.15% to 4,193.17. The U.S. has... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 41 Stocks Moving In Wednesday's Mid-Day Session April 28, 2021 Gainers Aurora Mobile Limited (NASDAQ: JG) shares climbed 21.3% to $4.27 after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per... Via Benzinga Mid-Morning Market Update: Markets Mixed; Alphabet Tops Q1 Expectations April 28, 2021 Following the market opening Wednesday, the Dow traded down 0.43% to 33,839.68 while the NASDAQ rose 0.10% to 14,104.41. The S&P also rose, gaining 0.19% to 4,194.68. The U.S... Via Benzinga Topics Stocks Exposures US Equities The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping April 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... Via Benzinga Exposures Product Safety 25 Stocks Moving in Wednesday's Pre-Market Session April 28, 2021 Gainers RiceBran Technologies (NASDAQ: RIBT) rose 16.1% to $1.37 in pre-market trading after jumping around 27% on Tuesday. The company is scheduled to report Q1 earnings today.... Via Benzinga Protalix Stock Falls After FDA Slaps CRL For PRX-102 Application In Fabry Disease April 28, 2021 Protalix BioTherapeutics Inc (NYSE: PLX) and Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici, have received a Complete Response... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout April 27, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Understanding Protalix BioTherapeutics's Unusual Options Activity April 19, 2021 Protalix BioTherapeutics (AMEX:PLX) shares experienced unusual options activity on Monday. The stock price moved up to $6.25 following the option alert. Sentiment: BEARISH Option... Via Benzinga The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx April 24, 2021 Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... Via Benzinga Exposures Product Safety < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.